Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Country/Region as subject
Affiliation country
Publication year range
1.
J Infect Chemother ; 29(1): 26-32, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36100144

ABSTRACT

BACKGROUND: Several carbapenemases have been identified globally in Enterobacteriaceae. In Japan, IMP-type carbapenemase is the most prevalent, although cases of carbapenemase-producing Enterobacteriaceae (CPE) bacteremia are still scarce. The present case series and literature review aimed to elucidate the clinical characteristics and treatment strategies for IMP-type CPE bacteremia. METHODS: Clinical data on pediatric cases of IMP-type CPE bacteremia at the Tokyo Metropolitan Children's Medical Center between 2010 and 2020 were collected, and a review of past studies of IMP-type CPE bacteremia has been provided. RESULTS: Five pediatric episodes of IMP-type CPE bacteremia were identified. Our review of previous literature on IMP-type CPE bacteremia revealed 24 adult patients, but no pediatric patients. All 29 cases had underlying diseases, and 23 (79%) received combination therapy. The median duration of antibiotic therapy was 14 days (interquartile range: 9-14 days). The overall mortality rate was 38% (11/29). The mortality rates associated with monotherapy and combination therapy were 67% (4/6) and 30% (7/23), respectively. CONCLUSIONS: We report the first case series of IMP-type CPE bacteremia in children. Our review of past studies suggests that combination therapy might lead to better survival outcomes in patients with IMP-type CPE bacteremia. Further research is needed to establish an optimal treatment strategy for IMP-type CPE bacteremia.


Subject(s)
Bacteremia , Carbapenem-Resistant Enterobacteriaceae , Enterobacteriaceae Infections , Adult , Child , Humans , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacterial Proteins , beta-Lactamases , Enterobacteriaceae , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/drug therapy , Microbial Sensitivity Tests
2.
J Infect Chemother ; 22(8): 532-5, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27263807

ABSTRACT

BACKGROUND: The spread of antimicrobial-resistant organisms is a global concern. To stem this tide, an antimicrobial stewardship program at hospitals is essential to optimize the prescription of broad spectrum antibiotics. In this study we examined the impact of computerized pre-authorization for broad spectrum antibiotics for Pseudomonas aeruginosa at a children's hospital. METHODS: An antimicrobial stewardship program at Tokyo Metropolitan Children's Medical Center was assessed between March 2010 and March 2015. A paper-based post-prescription audit was switched to computerized pre-authorization for broad antipseudomonal agents in October 2011. The prescriber was required to obtain approval from physicians in the pediatric infectious diseases division before prescribing restricted antimicrobial agents. Approved prescriptions were processed and logged electronically. We evaluated days of therapy per 1000 patient-days, the cost of antibiotics, and the susceptibility of P. aeruginosa to piperacillin, ceftazidime, cefepime, piperacillin/tazobactam, carbapenems, and ciprofloxacin. Also, the average length of admission and infection-related mortality at 30 days were compared pre- and post-intervention. RESULTS: Administration of carbapenems, piperacillin/tazobactam, and ceftazidime decreased significantly after the introduction of computerized pre-authorization. Antibiotic costs were reduced by JPY2.86 million (USD 26,000) annually. None of the antipseudomonal agents showed decreased sensitivity. The average length of admission was shorter in post-intervention. Infection-related mortality at 30 days showed no difference between the pre- and post-intervention periods. CONCLUSION: An antimicrobial stewardship program using computerized pre-authorization decreased the use and cost of broad spectrum antibiotics without significant difference in infection-related mortality at 30 days, although our study did not improve susceptibilities of P. aeruginosa.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/drug effects , Carbapenems/therapeutic use , Cefepime , Ceftazidime/therapeutic use , Cephalosporins/therapeutic use , Hospitals , Humans , Japan , Microbial Sensitivity Tests , Penicillanic Acid/analogs & derivatives , Penicillanic Acid/therapeutic use , Piperacillin/therapeutic use , Piperacillin, Tazobactam Drug Combination , Tokyo
4.
World J Gastroenterol ; 14(41): 6312-7, 2008 Nov 07.
Article in English | MEDLINE | ID: mdl-19009645

ABSTRACT

Neuropeptide Y (NPY) is a potent neurotransmitter for feeding. Besides NPY, orexigenic neuropeptides such as agouti-related protein (AgRP), and anorexigenic neuropeptides such as alpha-melatonin stimulating hormone (MSH) and cocaine-amphetamine-regulated transcript (CART) are also involved in central feeding regulation. During fasting, NPY and AgRP gene expressions are up-regulated and POMC and CART gene expressions are down-regulated in hypothalamus. Based on the network of peptidergic neurons, the former are involved in positive feeding regulation, and the latter are involved in negative feeding, which exert these feeding-regulated peptides especially in paraventricular nucleus (PVN). To clarify the compensatory mechanism of knock-out of NPY system on feeding, change in gene expressions of appetite-related neuropeptides and the feeding behavior was studied in NPY Y5-KO mice. Food intake was increased in Y5-KO mice. Fasting increased the amounts of food and water intake in the KO mice more profoundly. These data indicated the compensatory phenomenon of feeding behavior in Y5-KO mice. RT-PCR and ISH suggested that the compensation of feeding is due to change in gene expressions of AgRP, CART and POMC in hypothalamus. Thus, these findings indicated that the compensatory mechanism involves change in POMC/CART gene expression in arcuate nucleus (ARC). The POMC/CART gene expression is important for central compensatory regulation in feeding behavior.


Subject(s)
Appetite Regulation/genetics , Feeding Behavior , Hypothalamus/metabolism , Receptors, Neuropeptide Y/deficiency , Adaptation, Physiological , Agouti-Related Protein/metabolism , Animals , Body Weight , Drinking , Eating , Fasting , Female , Gene Expression Regulation , Hypothalamic Hormones/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Male , Melanins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Tissue Proteins/metabolism , Neuropeptide Y/metabolism , Neuropeptides/metabolism , Orexins , Pituitary Hormones/metabolism , Pro-Opiomelanocortin/metabolism , RNA, Messenger/metabolism , Receptors, Neuropeptide Y/genetics , Time Factors
6.
Am J Sports Med ; 32(5): 1297-301, 2004.
Article in English | MEDLINE | ID: mdl-15262656

ABSTRACT

BACKGROUND: The posterior segment of the lateral meniscus is relatively mobile as compared with that of the medial meniscus; that is because of its characteristic anatomy. Abnormal mobility of the lateral meniscus with no obvious rupture can be an unusual cause of knee pain and locking during deep knee flexion. PURPOSE: To evaluate results for a small series of patients with hypermobile lateral meniscus, treated with thermal shrinkage of the supporting ligaments. STUDY DESIGN: Series of case reports. METHOD: Five patients with hypermobile lateral meniscus were identified out of 625 patients who underwent meniscus surgery over a 20-month period. Thermal energy was applied to the peripheral zone of the lateral meniscus until abnormal translation was reduced. The patients were followed up an average of 21 months after the surgery. RESULTS: In 4 patients, no recurrence of locking was encountered in the postoperative period. In 1 patient, locking was experienced again 3 months after surgery and meniscal repair was performed. CONCLUSIONS: Thermal shrinkage can be considered an appropriate treatment in place of subtotal meniscectomy or meniscal repair for hypermobility of the lateral meniscus.


Subject(s)
Arthroscopy , Hot Temperature/therapeutic use , Hyperthermia, Induced/methods , Menisci, Tibial/physiopathology , Menisci, Tibial/surgery , Movement/physiology , Adolescent , Adult , Female , Humans , Male , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL